Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
33
SGMO Quote, Financials, Valuation and Earnings
Last price:
$0.48
Seasonality move
:
0.65%
Day range:
$0.47 - $0.49
52-week range:
$0.37 - $3.18
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.60x
P/B ratio:
24.08x
Volume:
2.3M
Avg. volume:
5.2M
1-year change:
4.72%
Market cap:
$118.1M
Revenue:
$57.8M
EPS (TTM):
-$0.39
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $118.2M | $110.7M | $111.3M | $176.2M | $57.8M | |
| Revenue Growth (YoY) | 15.39% | -6.34% | 0.54% | 58.34% | -67.2% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $180.6M | $230.8M | $249.9M | $234.1M | $111.5M | |
| Selling, General & Admin | $67.1M | $63.2M | $62.7M | $61.2M | $44.7M | |
| Other Inc / (Exp) | -- | -- | -- | -$155M | -$5.5M | |
| Operating Expenses | $247.7M | $294M | $312.6M | $295.2M | $156.2M | |
| Operating Income | -$129.6M | -$183.3M | -$201.3M | -$119M | -$98.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$120.8M | -$178M | -$191.8M | -$262.9M | -$98.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $345K | $306K | $429K | -$5.1M | -$167K | |
| Net Income to Company | -$121.1M | -$178.3M | -$192.3M | -$257.8M | -$97.9M | |
| Minority Interest in Earnings | $126K | $11K | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$121M | -$178.3M | -$192.3M | -$257.8M | -$97.9M | |
| Basic EPS (Cont. Ops) | -$0.90 | -$1.23 | -$1.25 | -$1.48 | -$0.49 | |
| Diluted EPS (Cont. Ops) | -$0.90 | -$1.23 | -$1.25 | -$1.48 | -$0.49 | |
| Weighted Average Basic Share | $134.4M | $144.6M | $154.3M | $174.4M | $201.7M | |
| Weighted Average Diluted Share | $134.4M | $144.6M | $154.3M | $174.4M | $201.7M | |
| EBITDA | -$116.2M | -$165.7M | -$180.7M | -$96.8M | -$89.1M | |
| EBIT | -$129.6M | -$183.3M | -$201.3M | -$119M | -$98.4M | |
| Revenue (Reported) | $118.2M | $110.7M | $111.3M | $176.2M | $57.8M | |
| Operating Income (Reported) | -$129.6M | -$183.3M | -$201.3M | -$119M | -$98.4M | |
| Operating Income (Adjusted) | -$129.6M | -$183.3M | -$201.3M | -$119M | -$98.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $26.3M | $28.2M | $158M | $481K | $6.4M | |
| Revenue Growth (YoY) | 100.98% | 7.42% | 459.52% | -99.7% | 1238.25% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $56.4M | $58.6M | $63.2M | $35.9M | $26M | |
| Selling, General & Admin | $16.1M | $14.9M | $18.1M | $11.8M | $10.1M | |
| Other Inc / (Exp) | -- | -- | -$58.6M | -$2.3M | -$1.2M | |
| Operating Expenses | $72.6M | $73.5M | $81.4M | $47.7M | $36.1M | |
| Operating Income | -$46.3M | -$45.3M | $76.6M | -$47.2M | -$29.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$45.7M | -$43.9M | $21.3M | -$49M | -$30.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $262K | $58K | $194K | $98K | $119K | |
| Net Income to Company | -$45.9M | -$44M | $21.1M | -$49.1M | -$30.6M | |
| Minority Interest in Earnings | $6K | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$45.9M | -$44M | $21.1M | -$49.1M | -$30.6M | |
| Basic EPS (Cont. Ops) | -$0.32 | -$0.30 | $0.13 | -$0.27 | -$0.14 | |
| Diluted EPS (Cont. Ops) | -$0.32 | -$0.30 | $0.12 | -$0.27 | -$0.14 | |
| Weighted Average Basic Share | $143.1M | $146.2M | $168.5M | $180.3M | $220.3M | |
| Weighted Average Diluted Share | $143.1M | $146.2M | $169.2M | $180.3M | $220.3M | |
| EBITDA | -$42.4M | -$40.3M | $82.2M | -$44.7M | -$27.7M | |
| EBIT | -$46.3M | -$45.3M | $76.6M | -$47.2M | -$29.6M | |
| Revenue (Reported) | $26.3M | $28.2M | $158M | $481K | $6.4M | |
| Operating Income (Reported) | -$46.3M | -$45.3M | $76.6M | -$47.2M | -$29.6M | |
| Operating Income (Adjusted) | -$46.3M | -$45.3M | $76.6M | -$47.2M | -$29.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $131.4M | $112.7M | $241M | $18.8M | $63.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $195.6M | $233M | $254.5M | $206.7M | $101.6M | |
| Selling, General & Admin | $67.1M | $62M | $65.9M | $54.8M | $43M | |
| Other Inc / (Exp) | -- | -- | -$58.6M | -$98.7M | -$2.3M | |
| Operating Expenses | $262.7M | $294.9M | $320.4M | $261.5M | $144.7M | |
| Operating Income | -$131.3M | -$182.3M | -$79.4M | -$242.8M | -$80.9M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$123.5M | -$176.2M | -$126.6M | -$333.2M | -$79.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $607K | $101K | $565K | -$5.2M | -$146K | |
| Net Income to Company | -$124.1M | -$176.3M | -$127.2M | -$328.1M | -$79.4M | |
| Minority Interest in Earnings | $71K | $5K | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$124M | -$176.3M | -$127.2M | -$328.1M | -$79.4M | |
| Basic EPS (Cont. Ops) | -$0.88 | -$1.22 | -$0.82 | -$1.86 | -$0.38 | |
| Diluted EPS (Cont. Ops) | -$0.88 | -$1.22 | -$0.83 | -$1.86 | -$0.39 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$117.3M | -$163.6M | -$58.2M | -$223.6M | -$72.1M | |
| EBIT | -$131.3M | -$182.3M | -$79.4M | -$242.8M | -$80.9M | |
| Revenue (Reported) | $131.4M | $112.7M | $241M | $18.8M | $63.8M | |
| Operating Income (Reported) | -$131.3M | -$182.3M | -$79.4M | -$242.8M | -$80.9M | |
| Operating Income (Adjusted) | -$131.3M | -$182.3M | -$79.4M | -$242.8M | -$80.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $26.3M | $28.2M | $158M | $481K | $6.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $56.4M | $58.6M | $63.2M | $35.9M | $26M | |
| Selling, General & Admin | $16.1M | $14.9M | $18.1M | $11.8M | $10.1M | |
| Other Inc / (Exp) | -- | -- | -$58.6M | -$2.3M | -$1.2M | |
| Operating Expenses | $72.6M | $73.5M | $81.4M | $47.7M | $36.1M | |
| Operating Income | -$46.3M | -$45.3M | $76.6M | -$47.2M | -$29.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$45.7M | -$43.9M | $21.3M | -$49M | -$30.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $262K | $58K | $194K | $98K | $119K | |
| Net Income to Company | -$45.9M | -$44M | $21.1M | -$49.1M | -$30.6M | |
| Minority Interest in Earnings | $6K | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$45.9M | -$44M | $21.1M | -$49.1M | -$30.6M | |
| Basic EPS (Cont. Ops) | -$0.32 | -$0.30 | $0.13 | -$0.27 | -$0.14 | |
| Diluted EPS (Cont. Ops) | -$0.32 | -$0.30 | $0.12 | -$0.27 | -$0.14 | |
| Weighted Average Basic Share | $143.1M | $146.2M | $168.5M | $180.3M | $220.3M | |
| Weighted Average Diluted Share | $143.1M | $146.2M | $169.2M | $180.3M | $220.3M | |
| EBITDA | -$42.4M | -$40.3M | $82.2M | -$44.7M | -$27.7M | |
| EBIT | -$46.3M | -$45.3M | $76.6M | -$47.2M | -$29.6M | |
| Revenue (Reported) | $26.3M | $28.2M | $158M | $481K | $6.4M | |
| Operating Income (Reported) | -$46.3M | -$45.3M | $76.6M | -$47.2M | -$29.6M | |
| Operating Income (Adjusted) | -$46.3M | -$45.3M | $76.6M | -$47.2M | -$29.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $131.3M | $178.9M | $100.4M | $45.2M | $41.9M | |
| Short Term Investments | $510.1M | $197.7M | $177.2M | $35.8M | -- | |
| Accounts Receivable, Net | $5.2M | $6M | $3.7M | $923K | $526K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $12M | $15.9M | $18.2M | $9.3M | $5.2M | |
| Total Current Assets | $659.7M | $398.8M | $300.3M | $94.3M | $51.7M | |
| Property Plant And Equipment | $112.4M | $124.7M | $125.5M | $52.9M | $34.8M | |
| Long-Term Investments | $50.5M | $88.2M | $29.8M | -- | -- | |
| Goodwill | $42.8M | $39.7M | $37.6M | -- | -- | |
| Other Intangibles | $58.1M | $53.8M | $50.7M | -- | -- | |
| Other Long-Term Assets | $15.1M | $16.8M | $18.5M | $2.8M | $2.4M | |
| Total Assets | $938.6M | $721.9M | $562.5M | $165.3M | $101.6M | |
| Accounts Payable | $12.6M | $9.8M | $22.4M | $15.3M | $15.5M | |
| Accrued Expenses | $9.9M | $7.6M | $11.9M | $19M | $3.9M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $3.7M | $4M | $4.1M | $4.6M | $4.3M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $143.5M | $127.9M | $111.7M | $47.7M | $45.8M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $441.2M | $346.6M | $267.6M | $82.4M | $78.9M | |
| Common Stock | $1.4M | $1.5M | $1.7M | $1.8M | $2.1M | |
| Other Common Equity Adj | $5.4M | -$4M | -$8.4M | -$4.6M | -$7.5M | |
| Common Equity | $498.2M | $375.3M | $295M | $82.9M | $22.8M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -$868K | -- | -- | -- | -- | |
| Total Equity | $497.4M | $375.3M | $295M | $82.9M | $22.8M | |
| Total Liabilities and Equity | $938.6M | $721.9M | $562.5M | $165.3M | $101.6M | |
| Cash and Short Terms | $641.4M | $376.5M | $277.6M | $81M | $41.9M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $123M | $120.3M | $78.2M | $54.4M | $25.2M | |
| Short Term Investments | $464.1M | $197.5M | $127.1M | -- | -- | |
| Accounts Receivable, Net | $6.7M | $6.9M | $7M | $691K | $366K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $12.1M | $15M | $13.7M | $12.6M | $7.8M | |
| Total Current Assets | $606.9M | $340.1M | $227.1M | $68.6M | $37.6M | |
| Property Plant And Equipment | $115.5M | $122.5M | $108.6M | $43M | $32.8M | |
| Long-Term Investments | $42.4M | $82.5M | $35.6M | -- | -- | |
| Goodwill | $41M | $38.9M | -- | -- | -- | |
| Other Intangibles | $55.6M | $52.7M | $51.6M | -- | -- | |
| Other Long-Term Assets | $15.6M | $17.6M | $17.7M | -- | $2.4M | |
| Total Assets | $877.1M | $654.3M | $440.6M | $129M | $86.2M | |
| Accounts Payable | $11.6M | $11.1M | $19.9M | $15.5M | $18.2M | |
| Accrued Expenses | $13.8M | $14.1M | $15.4M | $18.5M | $9.8M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $132.8M | $118.5M | $57.8M | $40.2M | $49.6M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $407.7M | $319.8M | $105M | $72.3M | $81.3M | |
| Common Stock | $1.4M | $1.5M | $1.7M | $2M | $2.3M | |
| Other Common Equity Adj | $714K | -$7M | -$5.8M | -$5.8M | -$5.5M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -$938K | -- | -- | -- | -- | |
| Total Equity | $469.4M | $334.5M | $335.6M | $56.7M | $4.9M | |
| Total Liabilities and Equity | $877.1M | $654.3M | $440.6M | $129M | $86.2M | |
| Cash and Short Terms | $587.1M | $317.8M | $205.4M | $54.4M | $25.2M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$121.1M | -$178.3M | -$192.3M | -$257.8M | -$97.9M | |
| Depreciation & Amoritzation | $13.4M | $17.6M | $20.6M | $22.2M | $9.4M | |
| Stock-Based Compensation | $25.7M | $33M | $31.7M | $27.4M | $12.4M | |
| Change in Accounts Receivable | $31.3M | -$103K | $1.9M | -$976K | $953K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $169.9M | -$233.3M | -$223.6M | -$224.8M | -$67.1M | |
| Capital Expenditures | $14.7M | $23.3M | $20.2M | $21.2M | $267K | |
| Cash Acquisitions | -$704K | -$119K | -- | -- | -- | |
| Cash From Investing | -$271.6M | $248.2M | $59.3M | $153.5M | $37.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$765K | -$3.3M | -$2.1M | -$1.5M | -$904K | |
| Cash From Financing | $153.1M | $32.9M | $84.7M | $14.6M | $28.4M | |
| Beginning Cash (CF) | $81.9M | $132.8M | $180.4M | $101.9M | $46.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $51.3M | $47.8M | -$79.7M | -$56.7M | -$1.2M | |
| Ending Cash (CF) | $132.8M | $180.4M | $101.9M | $46.7M | $43.4M | |
| Levered Free Cash Flow | $155.2M | -$256.5M | -$243.8M | -$246M | -$67.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$45.9M | -$44M | $21.1M | -$49.1M | -$30.6M | |
| Depreciation & Amoritzation | $3.9M | $4.9M | $5.6M | $2.5M | $1.9M | |
| Stock-Based Compensation | $7.5M | $7.7M | $8.3M | $2.7M | $2.6M | |
| Change in Accounts Receivable | -$1.5M | -$932K | -$3.6M | -$1.2M | $160K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$68.6M | -$59M | -$66.3M | -$48.7M | -$26.1M | |
| Capital Expenditures | $8M | $2.8M | $10.2M | -- | -- | |
| Cash Acquisitions | -$65K | -- | -- | -- | -- | |
| Cash From Investing | $45.3M | $1.7M | $35.7M | $35.8M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$2.2M | -$1.6M | -$1.1M | -$402K | -$2.2M | |
| Cash From Financing | $15.2M | -$1.6M | $8M | $22.1M | $8.1M | |
| Beginning Cash (CF) | $132.8M | $180.4M | $101.9M | $46.7M | $43.4M | |
| Foreign Exchange Rate Adjustment | -$328K | $222K | $367K | -$670K | $1.3M | |
| Additions / Reductions | -$8M | -$58.8M | -$22.6M | $9.3M | -$18M | |
| Ending Cash (CF) | $124.5M | $121.8M | $79.7M | $55.3M | $26.7M | |
| Levered Free Cash Flow | -$76.5M | -$61.8M | -$76.5M | -$48.7M | -$26.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$124.1M | -$176.3M | -$127.2M | -$328.1M | -$79.4M | |
| Depreciation & Amoritzation | $14.1M | $18.7M | $21.2M | $19.1M | $8.8M | |
| Stock-Based Compensation | $27.6M | $33.1M | $32.2M | $21.8M | $12.3M | |
| Change in Accounts Receivable | $115K | $487K | -$755K | $1.4M | $2.3M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $120.2M | -$223.7M | -$231M | -$207.2M | -$44.6M | |
| Capital Expenditures | $18.9M | $18.2M | $27.5M | $11M | $267K | |
| Cash Acquisitions | -$769K | -$54K | -- | -- | -- | |
| Cash From Investing | -$250.1M | $204.6M | $93.3M | $153.6M | $1.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$2.6M | -$2.7M | -$1.6M | -$746K | -$2.7M | |
| Cash From Financing | $167.9M | $16.1M | $94.2M | $28.7M | $14.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $38.1M | -$3M | -$43.4M | -$24.9M | -$28.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $101.3M | -$241.8M | -$258.5M | -$218.2M | -$44.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$45.9M | -$44M | $21.1M | -$49.1M | -$30.6M | |
| Depreciation & Amoritzation | $3.9M | $4.9M | $5.6M | $2.5M | $1.9M | |
| Stock-Based Compensation | $7.5M | $7.7M | $8.3M | $2.7M | $2.6M | |
| Change in Accounts Receivable | -$1.5M | -$932K | -$3.6M | -$1.2M | $160K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$68.6M | -$59M | -$66.3M | -$48.7M | -$26.1M | |
| Capital Expenditures | $8M | $2.8M | $10.2M | -- | -- | |
| Cash Acquisitions | -$65K | -- | -- | -- | -- | |
| Cash From Investing | $45.3M | $1.7M | $35.7M | $35.8M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$2.2M | -$1.6M | -$1.1M | -$402K | -$2.2M | |
| Cash From Financing | $15.2M | -$1.6M | $8M | $22.1M | $8.1M | |
| Beginning Cash (CF) | $132.8M | $180.4M | $101.9M | $46.7M | $43.4M | |
| Foreign Exchange Rate Adjustment | -$328K | $222K | $367K | -$670K | $1.3M | |
| Additions / Reductions | -$8M | -$58.8M | -$22.6M | $9.3M | -$18M | |
| Ending Cash (CF) | $124.5M | $121.8M | $79.7M | $55.3M | $26.7M | |
| Levered Free Cash Flow | -$76.5M | -$61.8M | -$76.5M | -$48.7M | -$26.1M | |
Get SGMO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SGMO
Sector
P/E ratio
--
23.88x
PEG ratio
-0.04x
0.00x
P/B ratio
24.08x
1.80x
Price / LTM sales
1.60x
1.65x
Growth Metrics
SGMO
Sector
Revenue growth
1238.25%
4.06%
Earnings growth
--
7.46%
Revenue (5-year growth)
-10.81%
8.01%
Earnings forecast
-$0.13
-$0.20
Profitability
SGMO
Sector
Profitability FY 2025
--
$47.5M
Return on invested capital
-269.87%
-16.26%
Return on assets
-76.24%
-13.27%
Return on equity
-269.87%
-18.61%
Earnings Date
Last Earnings Date
May
12
Next Earnings Date
Aug
8
Estimated Next Earnings Date
Aug
11
Balance Sheet
SGMO
Sector
Total cash
$25.2M
$35.5M
Short term investments
--
$29.7M
Total assets
$101.6M
$106.9M
Long term debt
--
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
